Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma	Active, not recruiting	Phase 2	2026-05-08		NCT04414540

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
American Cancer Society, Inc.	60
Trisha Wise-Draper	3

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Cincinnati Medical Center	Cincinnati	United States	83

Clinical trials